Evidence map›Paper›PMID 37790345›Full record

ArticlebioRxiv : the preprint server for biology2023

Characterization and optimization of variability in a human colonic epithelium culture model.

Colleen M Pike, Bailey Zwarycz, Bryan E McQueen, Mariana Castillo, Catherine Barron, Jeremy M Morowitz, James A Levi, Dhiral Phadke, Michele Balik-Meisner, Deepak Mav and 6 more

Open access · greenAbstract readPreprint
In one paragraph

Article in bioRxiv : the preprint server for biology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 6 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

16 authors.

Colleen M PikeAltis Biosystems, Inc. Durham, USA.
Bailey ZwaryczAltis Biosystems, Inc. Durham, USA.
Bryan E McQueenAltis Biosystems, Inc. Durham, USA.
Mariana CastilloAltis Biosystems, Inc. Durham, USA.
Catherine BarronAltis Biosystems, Inc. Durham, USA.
Jeremy M MorowitzAltis Biosystems, Inc. Durham, USA.
James A LeviAltis Biosystems, Inc. Durham, USA.
Dhiral PhadkeSciome, Durham, USA.
Michele Balik-MeisnerSciome, Durham, USA.
Deepak MavSciome, Durham, USA.
Ruchir ShahSciome, Durham, USA.
Danielle L Cunningham GlasspooleAltis Biosystems, Inc. Durham, USA.
Ron LaethamAltis Biosystems, Inc. Durham, USA.
William ThelinAltis Biosystems, Inc. Durham, USA.
Maureen K BungerAltis Biosystems, Inc. Durham, USA.
Elizabeth M BoazakAltis Biosystems, Inc. Durham, USA.

Funding

Virology Research Program (Program 4)P30CA016086 · NCI · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Deborah F. Tate · 1985 to 2026
$201.5M
PILOT AND FEASIBILITY STUDIESP30DK034987 · NIDDK · UNIV OF NORTH CAROLINA CHAPEL HILL · PI ROBERT S. SANDLER · 1985 to 2026
$30.5M
A Mucus-producing Intestinal Epithelium Model for In Vitro Drug Absorption TestingR43DK130708 · NIDDK · ALTIS BIOSYSTEMS, INC. · PI SIMS, CHRISTOPHER ELDRIDGE, THELIN, BILL · 2022 to 2022
$294k
Planar culture of gastrointestinal stem cells for screening pharmaceuticals for adverse event riskR43TR004230 · NCATS · ALTIS BIOSYSTEMS, INC. · PI SIMS, CHRISTOPHER ELDRIDGE, THELIN, BILL · 2022 to 2022
$257k
NCATS NIH HHS R43 TR004230NCI NIH HHS P30 CA016086NIDDK NIH HHS P30 DK034987NIDDK NIH HHS R43 DK130708
6 · The paper itself

Abstract

Animal models have historically been poor preclinical predictors of gastrointestinal (GI) directed therapeutic efficacy and drug-induced GI toxicity. Human stem and primary cell-derived culture systems are a major focus of efforts to create biologically relevant models that enhance preclinical predictive value of intestinal efficacy and toxicity. The inherent variability in stem-cell-based complex cultures makes development of useful models a challenge; the stochastic nature of stem-cell differentiation interferes with the ability to build and validate robust, reproducible assays that query drug responses and pharmacokinetics. In this study, we aimed to characterize and reduce potential sources of variability in a complex stem cell-derived intestinal epithelium model, termed RepliGut

Indexed as

intestinal barrierin vitro modelsmicrophysiological systemstransepithelial electrical resistance

Identifiers

PMID37790345
PMCPMC10542543
OpenAlexW4386981002

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.